while this pilot study suggests that okt3 can be used safely in the bone marrow transplantation setting , further modification of our okt3 treatment procedure will be necessary to completely eradicate graft-vs.-host disease in histocompatible bone marrow transplantation .
C0085379
okt3
C0018133
graft-vs